Weight loss drugs transforming healthcare, may help with addiction

Weight loss drugs transforming healthcare, may help with addiction

Speakers at the RushHourDaily Events Total Health conference in Chicago this week stated that a new class of weight loss drugs is revolutionizing the U.S. healthcare system and could have implications for other difficult-to-treat conditions like substance abuse. The U.S. Food and Drug Administration recently approved Eli Lilly’s drug tirzepatide for weight loss, making it the second obesity drug in the GLP-1s class. Novo Nordisk’s Wegovy, or semaglutide, was approved for obesity in 2021. These drugs mimic the action of the GLP-1 hormone to regulate blood sugar, slow digestion, and suppress appetite. Studies have shown that Wegovy led to a 15% weight loss over 68 weeks, while Lilly’s drug resulted in more than 22% weight loss over 72 weeks. Lawrence Tabak, principal deputy director at the U.S. National Institutes of Health (NIH), believes that these drugs offer new possibilities for controlling obesity, metabolism, and other addictive conditions. Walgreens has reported significant demand for GLP-1s, but reimbursement by health insurers has not yet caught up with the demand. The drugs have high list prices, but Tabak believes that over time, the cost may decrease. He also highlights the potential for lower overall healthcare costs if obesity is better controlled, leading to reductions in cardiovascular disease and related conditions. While there has been speculation about the impact of these drugs on consumer habits, Walgreens has not observed any significant changes in snack food purchases. However, they are open to adjusting their offerings based on consumer preferences. Overall, these weight loss drugs have the potential to transform healthcare and improve population health in the United States.

About News Team

News TeamHi, I'm Alex Perez, an experienced writer with a focus on lifestyle and culture news. From food and fashion to travel and entertainment, I love exploring the latest trends and sharing my insights with readers. I also have a strong interest in world news and business, and enjoy covering breaking stories and events.

Have a tip we should know? tips@rhd.news

Most Read

  1. News
    Pandora Papers Financial Leak Shows Us the Secrets of the World’s Rich and Powerful
    2 years ago
  2. Health
    US Supreme Court Rejects J & J TALC Cancer Case Appeal
    3 years ago
  3. Lifestyle
    9 Habits that Drain your Daily Focus and How to Avoid Them
    3 years ago
    Women’s Demand for Shapewear – the big Trends
    3 years ago
    Valentino Launches its Cosmetics Line
    3 years ago
  6. Health
    US Promises to Share 60 million Doses of AstraZeneca Vaccines
    3 years ago
  7. Health
    UK Offers Aid Amid Surging COVID-19 Cases in India
    3 years ago
  8. Sports
    Thousands of fans welcome Charlton funeral cortege at Old Trafford
    4 weeks ago
  9. News
    Brit left fighting for life after train derails in Argentinia
    4 weeks ago
    Dubai faces down airline rivals with $50 bln jet orders
    4 weeks ago
  11. Sunak
    UK’s Sunak brings back Cameron, sacks Braverman
    4 weeks ago
  12. Sports
    Man United’s Hojlund, Eriksen withdrawn from Denmark team duty
    4 weeks ago
  13. Health
    Autumn Sneezing Syndrome is on the rise… here’s what you can do
    4 weeks ago
  14. Canada
    Canada beat Italy to win Billie Jean King Cup for first time
    4 weeks ago

Follow @rushhourdaily: